Lou Gehrig’s Disease: Progress and Promise in Stem Cell Research

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

CIRM has funded the ALS Disease Team led by scientists at UC San Diego, The Salk Institute, and Life Technologies Corporation, who aim to bring a human embryonic stem cell-based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years from the onset of symptoms.

Learn more about ALS: http://bit.ly/ALSNewsToday